The research team at Universite Laval is addressing a wide range of global health and wellbeing challenges, from chronic diseases to mental health conditions.
Their internationally-recognised work spans a vast range of health fields, including cardiology, oncology, respiratory health, infectious diseases, mental health, and public health.
The university's recent associate membership in Horizon Europe enhances its capacity for innovation.
Read the Entire Article
A customized collection of news from foundations from around the Web.
Nonprofit impact investing firm, Acumen, has invested $1.2 million to KZ Noir, a Rwanda-based coffee processing company owned by Kaizen Venture Partners. The investment will equip KZ Noir the funds for working capital, debt refinancing, and capacity expansion.